Prelude Therapeutics Inc (PRLD) › RevenuePrelude Therapeutics Inc (PRLD) — RevenueAnnual figures by fiscal year, from SEC filings.2024: $7.00M2025: $12.14M$12.14M2024Revenue (USD)2025Fiscal YearRevenueChange YoY2025$12.14M+73.4%2024$7.00M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share